Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
1.
J Atten Disord ; 22(3): 281-292, 2018 02.
Article de Anglais | MEDLINE | ID: mdl-26374770

RÉSUMÉ

OBJECTIVE: To characterize heterogeneity in adults with ADHD we aimed to identify subgroups within the adult ADHD spectrum, which differ in their cognitive profile. METHOD: Neuropsychological data from adults with ADHD ( n = 133) and healthy control participants ( n = 132) were used in a confirmatory factor analysis. The resulting six cognitive factors were correlated across participants to form networks. We used a community detection algorithm to cluster these networks into subgroups. RESULTS: Both the ADHD and control group separated into three profiles that differed in cognitive performance. Profile 1 was characterized by aberrant attention and inhibition, profile 2 by increased delay discounting, and profile 3 by atypical working memory and verbal fluency. CONCLUSION: Our findings suggest that qualitative differences in neuropsychological performance exist in both control and ADHD adult individuals. This extends prior findings in children with and without ADHD and provides a framework to parse participants into well-defined subgroups.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité/psychologie , Attention/physiologie , Cognition/physiologie , Dévalorisation de la gratification différée , Inhibition psychologique , Mémoire à court terme/physiologie , Tests neuropsychologiques , Adulte , Études cas-témoins , Enfant , Fonction exécutive , Femelle , Humains , Mâle
2.
Lancet Psychiatry ; 4(4): 310-319, 2017 04.
Article de Anglais | MEDLINE | ID: mdl-28219628

RÉSUMÉ

BACKGROUND: Neuroimaging studies have shown structural alterations in several brain regions in children and adults with attention deficit hyperactivity disorder (ADHD). Through the formation of the international ENIGMA ADHD Working Group, we aimed to address weaknesses of previous imaging studies and meta-analyses, namely inadequate sample size and methodological heterogeneity. We aimed to investigate whether there are structural differences in children and adults with ADHD compared with those without this diagnosis. METHODS: In this cross-sectional mega-analysis, we used the data from the international ENIGMA Working Group collaboration, which in the present analysis was frozen at Feb 8, 2015. Individual sites analysed structural T1-weighted MRI brain scans with harmonised protocols of individuals with ADHD compared with those who do not have this diagnosis. Our primary outcome was to assess case-control differences in subcortical structures and intracranial volume through pooling of all individual data from all cohorts in this collaboration. For this analysis, p values were significant at the false discovery rate corrected threshold of p=0·0156. FINDINGS: Our sample comprised 1713 participants with ADHD and 1529 controls from 23 sites with a median age of 14 years (range 4-63 years). The volumes of the accumbens (Cohen's d=-0·15), amygdala (d=-0·19), caudate (d=-0·11), hippocampus (d=-0·11), putamen (d=-0·14), and intracranial volume (d=-0·10) were smaller in individuals with ADHD compared with controls in the mega-analysis. There was no difference in volume size in the pallidum (p=0·95) and thalamus (p=0·39) between people with ADHD and controls. Exploratory lifespan modelling suggested a delay of maturation and a delay of degeneration, as effect sizes were highest in most subgroups of children (<15 years) versus adults (>21 years): in the accumbens (Cohen's d=-0·19 vs -0·10), amygdala (d=-0·18 vs -0·14), caudate (d=-0·13 vs -0·07), hippocampus (d=-0·12 vs -0·06), putamen (d=-0·18 vs -0·08), and intracranial volume (d=-0·14 vs 0·01). There was no difference between children and adults for the pallidum (p=0·79) or thalamus (p=0·89). Case-control differences in adults were non-significant (all p>0·03). Psychostimulant medication use (all p>0·15) or symptom scores (all p>0·02) did not influence results, nor did the presence of comorbid psychiatric disorders (all p>0·5). INTERPRETATION: With the largest dataset to date, we add new knowledge about bilateral amygdala, accumbens, and hippocampus reductions in ADHD. We extend the brain maturation delay theory for ADHD to include subcortical structures and refute medication effects on brain volume suggested by earlier meta-analyses. Lifespan analyses suggest that, in the absence of well powered longitudinal studies, the ENIGMA cross-sectional sample across six decades of ages provides a means to generate hypotheses about lifespan trajectories in brain phenotypes. FUNDING: National Institutes of Health.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité/anatomopathologie , Encéphale/anatomopathologie , Imagerie par résonance magnétique , Adolescent , Adulte , Trouble déficitaire de l'attention avec hyperactivité/physiopathologie , Encéphale/physiopathologie , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Études transversales , Femelle , Humains , Modèles linéaires , Études longitudinales , Mâle , Adulte d'âge moyen , Neuroimagerie , Jeune adulte
3.
Biol Psychiatry ; 82(9): 634-641, 2017 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-27890468

RÉSUMÉ

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BPD) are frequently co-occurring and highly heritable mental health conditions. We hypothesized that BPD cases with an early age of onset (≤21 years old) would be particularly likely to show genetic covariation with ADHD. METHODS: Genome-wide association study data were available for 4609 individuals with ADHD, 9650 individuals with BPD (5167 thereof with early-onset BPD), and 21,363 typically developing controls. We conducted a cross-disorder genome-wide association study meta-analysis to identify whether the observed comorbidity between ADHD and BPD could be due to shared genetic risks. RESULTS: We found a significant single nucleotide polymorphism-based genetic correlation between ADHD and BPD in the full and age-restricted samples (rGfull = .64, p = 3.13 × 10-14; rGrestricted = .71, p = 4.09 × 10-16). The meta-analysis between the full BPD sample identified two genome-wide significant (prs7089973 = 2.47 × 10-8; prs11756438 = 4.36 × 10-8) regions located on chromosomes 6 (CEP85L) and 10 (TAF9BP2). Restricting the analyses to BPD cases with an early onset yielded one genome-wide significant association (prs58502974 = 2.11 × 10-8) on chromosome 5 in the ADCY2 gene. Additional nominally significant regions identified contained known expression quantitative trait loci with putative functional consequences for NT5DC1, NT5DC2, and CACNB3 expression, whereas functional predictions implicated ABLIM1 as an allele-specific expressed gene in neuronal tissue. CONCLUSIONS: The single nucleotide polymorphism-based genetic correlation between ADHD and BPD is substantial, significant, and consistent with the existence of genetic overlap between ADHD and BPD, with potential differential genetic mechanisms involved in early and later BPD onset.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité/génétique , Trouble bipolaire/génétique , Comorbidité , Étude d'association pangénomique/méthodes , Trouble déficitaire de l'attention avec hyperactivité/épidémiologie , Trouble bipolaire/épidémiologie , Humains
4.
Nat Neurosci ; 19(3): 420-431, 2016 Mar.
Article de Anglais | MEDLINE | ID: mdl-26854805

RÉSUMÉ

Schizophrenia is a devastating psychiatric illness with high heritability. Brain structure and function differ, on average, between people with schizophrenia and healthy individuals. As common genetic associations are emerging for both schizophrenia and brain imaging phenotypes, we can now use genome-wide data to investigate genetic overlap. Here we integrated results from common variant studies of schizophrenia (33,636 cases, 43,008 controls) and volumes of several (mainly subcortical) brain structures (11,840 subjects). We did not find evidence of genetic overlap between schizophrenia risk and subcortical volume measures either at the level of common variant genetic architecture or for single genetic markers. These results provide a proof of concept (albeit based on a limited set of structural brain measures) and define a roadmap for future studies investigating the genetic covariance between structural or functional brain phenotypes and risk for psychiatric disorders.


Sujet(s)
Encéphale/anatomopathologie , Étude d'association pangénomique , Schizophrénie/génétique , Schizophrénie/anatomopathologie , Endophénotypes , Prédisposition génétique à une maladie/génétique , Humains , Déséquilibre de liaison , Imagerie par résonance magnétique , Neuroimagerie , Taille d'organe , Polymorphisme de nucléotide simple/génétique
5.
Addict Biol ; 21(4): 915-23, 2016 07.
Article de Anglais | MEDLINE | ID: mdl-25752199

RÉSUMÉ

Individuals with attention deficit/hyperactivity disorder (ADHD) are at increased risk of developing substance use disorders (SUDs) and nicotine dependence. The co-occurrence of ADHD and SUDs/nicotine dependence may in part be mediated by shared genetic liability. Several neurobiological pathways have been implicated in both ADHD and SUDs, including dopamine and serotonin pathways. We hypothesized that variations in dopamine and serotonin neurotransmission genes were involved in the genetic liability to develop SUDs/nicotine dependence in ADHD. The current study included participants with ADHD (n = 280) who were originally part of the Dutch International Multicenter ADHD Genetics study. Participants were aged 5-15 years and attending outpatient clinics at enrollment in the study. Diagnoses of ADHD, SUDs, nicotine dependence, age of first nicotine and substance use, and alcohol use severity were based on semi-structured interviews and questionnaires. Genetic risk scores were created for both serotonergic and dopaminergic risk genes previously shown to be associated with ADHD and SUDs and/or nicotine dependence. The serotonin genetic risk score significantly predicted alcohol use severity. No significant serotonin × dopamine risk score or effect of stimulant medication was found. The current study adds to the literature by providing insight into genetic underpinnings of the co-morbidity of ADHD and SUDs. While the focus of the literature so far has been mostly on dopamine, our study suggests that serotonin may also play a role in the relationship between these disorders.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité/épidémiologie , Dopamine/génétique , Prédisposition génétique à une maladie/épidémiologie , Sérotonine/génétique , Troubles liés à une substance/épidémiologie , Troubles liés à une substance/génétique , Adolescent , Adulte , Trouble déficitaire de l'attention avec hyperactivité/génétique , Comorbidité , Femelle , Études de suivi , Prédisposition génétique à une maladie/génétique , Humains , Mâle , Pays-Bas/épidémiologie , Facteurs de risque , Enquêtes et questionnaires , Trouble lié au tabagisme/épidémiologie , Trouble lié au tabagisme/génétique , Jeune adulte
6.
Am J Med Genet B Neuropsychiatr Genet ; 171(5): 573-88, 2016 07.
Article de Anglais | MEDLINE | ID: mdl-26184070

RÉSUMÉ

Oppositional defiant disorder (ODD) is a frequent psychiatric disorder seen in children and adolescents with attention-deficit-hyperactivity disorder (ADHD). ODD is also a common antecedent to both affective disorders and aggressive behaviors. Although the heritability of ODD has been estimated to be around 0.60, there has been little research into the molecular genetics of ODD. The present study examined the association of irritable and defiant/vindictive dimensions and categorical subtypes of ODD (based on latent class analyses) with previously described specific polymorphisms (DRD4 exon3 VNTR, 5-HTTLPR, and seven OXTR SNPs) as well as with dopamine, serotonin, and oxytocin genes and pathways in a clinical sample of children and adolescents with ADHD. In addition, we performed a multivariate genome-wide association study (GWAS) of the aforementioned ODD dimensions and subtypes. Apart from adjusting the analyses for age and sex, we controlled for "parental ability to cope with disruptive behavior." None of the hypothesis-driven analyses revealed a significant association with ODD dimensions and subtypes. Inadequate parenting behavior was significantly associated with all ODD dimensions and subtypes, most strongly with defiant/vindictive behaviors. In addition, the GWAS did not result in genome-wide significant findings but bioinformatics and literature analyses revealed that the proteins encoded by 28 of the 53 top-ranked genes functionally interact in a molecular landscape centered around Beta-catenin signaling and involved in the regulation of neurite outgrowth. Our findings provide new insights into the molecular basis of ODD and inform future genetic studies of oppositional behavior. © 2015 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité/génétique , Troubles déficitaires de l'attention et du comportement perturbateur/génétique , Troubles déficitaires de l'attention et du comportement perturbateur/psychologie , Adolescent , Agressivité/psychologie , Trouble déficitaire de l'attention avec hyperactivité/psychologie , Enfant , Femelle , Études d'associations génétiques/méthodes , Étude d'association pangénomique , Humains , Mâle , Pratiques éducatives parentales/psychologie , Parents , Polymorphisme de nucléotide simple/génétique
7.
Eur Neuropsychopharmacol ; 25(11): 2062-2074, 2015 Nov.
Article de Anglais | MEDLINE | ID: mdl-26336867

RÉSUMÉ

Attention Deficit/Hyperactivity Disorder (ADHD) in childhood is associated with impaired functioning in multiple cognitive domains: executive functioning (EF), reward and timing. Similar impairments have been described for adults with persistent ADHD, but an extensive investigation of neuropsychological functioning in a large sample of adult patients is currently lacking. We systematically examined neuropsychological performance on tasks measuring EF, delay discounting, time estimation and response variability using univariate ANCOVA's comparing patients with persistent ADHD (N=133, 42% male, mean age 36) and healthy adults (N=132, 40% male, mean age 36). In addition, we tested which combination of variables provided the highest accuracy in predicting ADHD diagnosis. We also estimated for each individual the severity of neuropsychological dysfunctioning. Lastly, we investigated potential effects of stimulant medication and a history of comorbid major depressive disorder (MDD) on performance. Compared to healthy adults, patients with ADHD showed impaired EF, were more impulsive, and more variable in responding. However, effect sizes were small to moderate (range: 0.05-0.70) and 11% of patients did not show neuropsychological dysfunctioning. The best fitting model predicting ADHD included measures from distinct cognitive domains (82.1% specificity, 64.9% sensitivity). Furthermore, patients receiving stimulant medication or with a history of MDD were not distinctively impaired. To conclude, while adults with ADHD as a group are impaired on several cognitive domains, the results confirm that adult ADHD is neuropsychologically heterogeneous. This provides a starting point to investigate individual differences in terms of impaired cognitive pathways.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité/psychologie , Cognition , Fonction exécutive , Adulte , Trouble déficitaire de l'attention avec hyperactivité/complications , Trouble déficitaire de l'attention avec hyperactivité/diagnostic , Trouble déficitaire de l'attention avec hyperactivité/traitement médicamenteux , Stimulants du système nerveux central/usage thérapeutique , Études de cohortes , Comorbidité , Dévalorisation de la gratification différée , Trouble dépressif majeur/complications , Femelle , Humains , Mâle , Adulte d'âge moyen , Modèles psychologiques , Pays-Bas , Tests neuropsychologiques , Échelles d'évaluation en psychiatrie , Sensibilité et spécificité , Perception du temps , Jeune adulte
8.
Am J Med Genet B Neuropsychiatr Genet ; 168(6): 492-507, 2015 Sep.
Article de Anglais | MEDLINE | ID: mdl-26061966

RÉSUMÉ

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neuropsychiatric disorder with a complex genetic background. The G protein-coupled receptor kinase interacting ArfGAP 1 (GIT1) gene was previously associated with ADHD. We aimed at replicating the association of GIT1 with ADHD and investigated its role in cognitive and brain phenotypes. Gene-wide and single variant association analyses for GIT1 were performed for three cohorts: (1) the ADHD meta-analysis data set of the Psychiatric Genomics Consortium (PGC, N = 19,210), (2) the Dutch cohort of the International Multicentre persistent ADHD CollaboraTion (IMpACT-NL, N = 225), and (3) the Brain Imaging Genetics cohort (BIG, N = 1,300). Furthermore, functionality of the rs550818 variant as an expression quantitative trait locus (eQTL) for GIT1 was assessed in human blood samples. By using Drosophila melanogaster as a biological model system, we manipulated Git expression according to the outcome of the expression result and studied the effect of Git knockdown on neuronal morphology and locomotor activity. Association of rs550818 with ADHD was not confirmed, nor did a combination of variants in GIT1 show association with ADHD or any related measures in either of the investigated cohorts. However, the rs550818 risk-genotype did reduce GIT1 expression level. Git knockdown in Drosophila caused abnormal synapse and dendrite morphology, but did not affect locomotor activity. In summary, we could not confirm GIT1 as an ADHD candidate gene, while rs550818 was found to be an eQTL for GIT1. Despite GIT1's regulation of neuronal morphology, alterations in gene expression do not appear to have ADHD-related behavioral consequences. © 2015 Wiley Periodicals, Inc.

9.
JAMA Psychiatry ; 72(5): 490-9, 2015 May.
Article de Anglais | MEDLINE | ID: mdl-25785435

RÉSUMÉ

IMPORTANCE: Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelopmental disorder. It has been linked to reductions in total brain volume and subcortical abnormalities. However, owing to heterogeneity within and between studies and limited sample sizes, findings on the neuroanatomical substrates of ADHD have shown considerable variability. Moreover, it remains unclear whether neuroanatomical alterations linked to ADHD are also present in the unaffected siblings of those with ADHD. OBJECTIVE: To examine whether ADHD is linked to alterations in whole-brain and subcortical volumes and to study familial underpinnings of brain volumetric alterations in ADHD. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, we included participants from the large and carefully phenotyped Dutch NeuroIMAGE sample (collected from September 2009-December 2012) consisting of 307 participants with ADHD, 169 of their unaffected siblings, and 196 typically developing control individuals (mean age, 17.21 years; age range, 8-30 years). MAIN OUTCOMES AND MEASURES: Whole-brain volumes (total brain and gray and white matter volumes) and volumes of subcortical regions (nucleus accumbens, amygdala, caudate nucleus, globus pallidus, hippocampus, putamen, thalamus, and brainstem) were derived from structural magnetic resonance imaging scans using automated tissue segmentation. RESULTS: Regression analyses revealed that relative to control individuals, participants with ADHD had a 2.5% smaller total brain (ß = -31.92; 95% CI, -52.69 to -11.16; P = .0027) and a 3% smaller total gray matter volume (ß = -22.51; 95% CI, -35.07 to -9.96; P = .0005), while total white matter volume was unaltered (ß = -10.10; 95% CI, -20.73 to 0.53; P = .06). Unaffected siblings had total brain and total gray matter volumes intermediate to participants with ADHD and control individuals. Significant age-by-diagnosis interactions showed that older age was linked to smaller caudate (P < .001) and putamen (P = .01) volumes (both corrected for total brain volume) in control individuals, whereas age was unrelated to these volumes in participants with ADHD and their unaffected siblings. Attention-deficit/hyperactivity disorder was not significantly related to the other subcortical volumes. CONCLUSIONS AND RELEVANCE: Global differences in gray matter volume may be due to alterations in the general mechanisms underlying normal brain development in ADHD. The age-by-diagnosis interaction in the caudate and putamen supports the relevance of different brain developmental trajectories in participants with ADHD vs control individuals and supports the role of subcortical basal ganglia alterations in the pathophysiology of ADHD. Alterations in total gray matter and caudate and putamen volumes in unaffected siblings suggest that these volumes are linked to familial risk for ADHD.


Sujet(s)
Développement de l'adolescent , Trouble déficitaire de l'attention avec hyperactivité/anatomopathologie , Encéphale/anatomopathologie , Noyau caudé/anatomopathologie , Développement de l'enfant , Imagerie par résonance magnétique , Putamen/anatomopathologie , Fratrie , Adolescent , Adulte , Facteurs âges , Amygdale (système limbique)/anatomopathologie , Trouble déficitaire de l'attention avec hyperactivité/physiopathologie , Trouble déficitaire de l'attention avec hyperactivité/psychologie , Encéphale/anatomie et histologie , Encéphale/physiopathologie , Tronc cérébral/anatomopathologie , Noyau caudé/anatomie et histologie , Noyau caudé/physiopathologie , Enfant , Études transversales , Femelle , Globus pallidus/anatomopathologie , Substance grise/anatomopathologie , Hippocampe/anatomopathologie , Humains , Imagerie par résonance magnétique/méthodes , Mâle , Noyau accumbens/anatomopathologie , Taille d'organe , Putamen/anatomie et histologie , Putamen/physiopathologie , Facteurs de risque , Thalamus/anatomopathologie , Substance blanche/anatomopathologie , Jeune adulte
10.
Psychiatr Genet ; 24(4): 125-50, 2014 Aug.
Article de Anglais | MEDLINE | ID: mdl-24912047

RÉSUMÉ

The XXI World Congress of Psychiatric Genetics (WCPG), sponsored by the International Society of Psychiatric Genetics (ISPG), took place in Boston, Massachusetts, on 17-21 October 2013. Approximately 900 participants gathered to discuss the latest findings in this rapidly advancing field. The following report was written by student travel awardees. Each was assigned one or more sessions as a rapporteur. This manuscript represents topics covered in most, but not all of the oral presentations during the conference, and contains some of the major notable new findings reported.


Sujet(s)
Troubles mentaux/génétique , Marqueurs biologiques/métabolisme , Boston , Endophénotypes , Réseaux de régulation génique , Dépistage génétique , Étude d'association pangénomique , Génomique , Humains , Mutation/génétique , Statistiques comme sujet , Cellules souches/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...